ALI/ARDS triggers pro-inflammatory cytokine and chemokine release via the NF-κB signaling pathway, but FXR inhibits this pathway and also blocks the MAPK and PI3K/Akt pathways (Fei et al., 2019). The gene discussed is AKT1; the disease is acute respiratory distress syndrome.